Medication info
Fosagenic Plus D Tablet

Fosagenic Plus D Tablet

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White to grayish-white rectangular tablet
Packaging
4 tablets (4 tablets/PTP X 1)
Approval status
Active

MFDS item code 201207689 · Approved 2012.11.05 · Insurance code 645403840

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medication (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming any food, drink, or other medication (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been determined. The safety and efficacy of this medication for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medication, or at the same time, may reduce the absorption of alendronate in the body and diminish its effect. Take this medication as soon as you get up in the morning and swallow it with a sufficient amount of water (170∼230 mL) to facilitate rapid passage into the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medication at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medication once weekly provides a weekly amount of vitamin D equivalent to 400 IU or 800 IU daily. If a patient taking 1 tablet of this medication forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day. Administration in older adults (65 years and older): No dose adjustment is necessary. Administration in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, administration of this medication is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), as clinical experience is insufficient.
Child dose
Children and adolescents (under 18 years): Safety and efficacy have not been established in children and adolescents.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medication (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming any food, drink, or other medication (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been determined. The safety and efficacy of this medication for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3~5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medication, or at the same time, may reduce the absorption of alendronate in the body and diminish its effect. Take this medication as soon as you get up in the morning and swallow it with a sufficient amount of water (170∼230 mL) to facilitate rapid passage into the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medication at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medication once weekly provides a weekly amount of vitamin D equivalent to 400 IU or 800 IU daily. If a patient taking 1 tablet of this medication forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day. Administration in older adults (65 years and older): No dose adjustment is necessary. Administration in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min). However, administration of this medication is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min), as clinical experience is insufficient.

Child dose

Children and adolescents (under 18 years): Safety and efficacy have not been established in children and adolescents.

Precautions

This medication may irritate the upper gastrointestinal tract, leading to symptoms such as esophagitis, esophageal ulcers, and esophageal erosion, so caution is required during use. Do not lie down for at least 30 minutes after taking, and take it with a sufficient amount of water. If any symptoms occur, you should stop taking it immediately and consult your doctor. Patients with diseases that delay esophageal emptying or hypocalcemia, and those who are hypersensitive to this medication should not take it. While taking this medication, gastrointestinal disturbances, abdominal pain, nausea, dyspepsia, diarrhea, musculoskeletal pain, and headaches may occur. Therefore, you should be cautious if any unusual symptoms are present. Particularly, patients with a history of gastrointestinal disease or those currently taking non-steroidal anti-inflammatory drugs should be cautious due to the increased risk of gastrointestinal irritation. If there is insufficient calcium intake, it is advisable to take supplements, and patients at high risk for vitamin D deficiency may require additional vitamin D supplementation. If pregnant or breastfeeding, administration of this medication should be carefully considered, and it is not to be used in children. Severely impaired renal function patients are not recommended to take it, so checking renal function prior to prescription is important. Overdose may lead to symptoms of hypocalcemia and gastrointestinal irritation, so immediate consultation with medical personnel is required. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized jawbone necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, vertigo, pruritus, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, rhinopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Also, it should be stored at room temperature between 1 to 30 degrees Celsius and protected from direct sunlight.

Appearance and packaging

Appearance

White to grayish-white rectangular tablet

Package unit

4 tablets (4 tablets/PTP X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.